Nigel George Wright

DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom.

Cambridge Display Technology ltd. develops display technologies based on polymer organic light emitting diodes (P-OLEDs). It primarily focuses on developing P-OLEDs for display and lighting applications, as well as organic semiconductor and photovoltaic applications. The firm specializes in the areas of materials development, device optimization and modeling, manufacturing processes, and intellectual property. The company was founded by Richard Friend, Jeremy Burroughes, and Donal Donat Conor Bradley on January 2, 1992 and is headquartered in Godmanchester, the United Kingdom.

Part of UCB SA, UCB Research, Inc. is a company that provides commercial physical research laboratory services. The company is based in Cambridge, MA.

Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

Part of Canon, Inc., Canon Medical Research Europe Ltd. is a British company founded in 2008 that provides digital imaging and scanning technologies to the medical sector. The company is based in Edinburgh, UK.

Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The company is based in London, UK. David Sproul has been the CEO of the British company since 2003.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level.

The Royal Society of Edinburgh provides investment advice. The non-profit company is based in Edinburgh, UK and has subsidiaries in the United Kingdom.

Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom.

One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls.

Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey.

Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

metaLinear Ltd. operates as a biotechnology firm. It uses proteome engineering technology to identify, validate, and drug new microbial targets. The company was founded by Paul Ko Ferrigno in November 2016 and is headquartered in Cheshire, the United Kingdom.

Fast BioPharma Ltd. develops therapeutic products for treatment of cancer. The company is headquartered in Watlington, the United Kingdom.

Kinoxis Therapeutics Pty Ltd. engages in conducting biotechnology research. The company is headquartered in Camberwell, Australia.

Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom.

Part of Nottingham Trent University, Confetti Constellations Ltd. supplies, designs, and installs music, moving image, and IT equipment furniture. The company is based in Nottingham, UK and was founded in 2005.

Part of Nottingham Trent University, Nova Centric Ltd. provides education courses. The company is based in Nottingham, UK. Nova Centric was founded in 2003.

Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker.

Dark Blue Therapeutics Ltd. operates as a biotechnology firm. The company was founded in June 4, 2020 an is headquartered in Oxford, the United Kingdom.

SecondPerspective Ltd. develops blood flow restriction training devices powered by artificial intelligence.

NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation.

We Are Pioneer Group Ltd. (Pioneer Group) is a venture capital firm founded in 2021. The firm is headquartered in London, United Kingdom.

Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby.

Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables.

AlveoGene Ltd. is a British dormant company that was founded in 2022. The company is based in Oxford, UK.